Identification of triptonide as a therapeutic agent for triple negative breast cancer treatment
Abstract Triple-negative breast cancer (TNBC) is associated with a high rate of early recurrence and distant metastasis, frequent development of therapeutic resistance, and a poor prognosis.There is a lack of targeted therapies for this aggressive subtype of breast cancer.Identifying novel effective treatment modalities for TNBC remains an urgent a